BA vs DLB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Boeing exhibits severe fundamental distress, characterized by a stable but mediocre Piotroski F-Score of 4/9 and a massive valuation gap, with the current price ($219.16) trading at a staggering premium over its Graham Number ($19.68) and Intrinsic Value ($17.36). While revenue growth is robust at 57.10%, the company suffers from negative operating margins and a dangerous Debt/Equity ratio of 10.33. The combination of bearish insider sentiment, a 0/100 technical trend, and poor liquidity (Quick Ratio 0.38) outweighs the optimistic analyst price targets.
DLB exhibits a dichotomy between exceptional financial health and poor growth momentum. The Piotroski F-Score of 8/9 indicates a very strong balance sheet with minimal debt (D/E 0.02) and high liquidity, yet the stock trades at a significant premium to its Graham Number ($38.84) and Intrinsic Value ($17.29). While the company maintains an elite gross margin of 87.86%, negative YoY revenue and earnings growth, coupled with bearish insider activity and a 0/100 technical trend, offset the strong fundamental health.
Compare Another Pair
BA vs DLB: Head-to-Head Comparison
This page compares The Boeing Company (BA) and Dolby Laboratories, Inc. (DLB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.